Lucas Oliveira Maia

Lucas Oliveira Maia

Auto-generated profile, based on publicly available information

Lucas Oliveira Maia

University of Campinas

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2013 in Journal of Psychopharmacology
Verified
Journal Article
Closed access
PDF file
MCMarcos Hortes N Chagas
Marcos Hortes N Chagas
JCJosé Alexandre S Crippa
José Alexandre S Crippa
AZAntonio Waldo Zuardi
Antonio Waldo Zuardi
JHJaime E C Hallak
Jaime E C Hallak
JMJoão Paulo Machado-De-Sousa
João Paulo Machado-De-Sousa
MAMonica Levy Andersen
Monica Levy Andersen
Cannabidiol (CBD) is one of the main components of Cannabis sativa and has a wide spectrum of action, including effects in the sleep-wake cycle.

11 February 2022 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
LMLucas Oliveira Maia
Lucas Oliveira Maia
YBYvan Beaussant
Yvan Beaussant
Ana Cláudia Mesquita GarciaAna Cláudia Mesquita Garcia
Ana Cláudia Mesquita Garcia

8 November 2022 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
LMLucas Oliveira Maia
Lucas Oliveira Maia
DDDimitri Daldegan-Bueno
Dimitri Daldegan-Bueno
IWIsabel Wießner
Isabel Wießner
DADraulio B. Araujo
Draulio B. Araujo
LTLuís Fernando Tófoli
Luís Fernando Tófoli

11 February 2022 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
IWIsabel Wießner
Isabel Wießner
RORodolfo Olivieri
Rodolfo Olivieri
MFMarcelo Falchi
Marcelo Falchi
FPFernanda Palhano-Fontes
Fernanda Palhano-Fontes
LMLucas Oliveira Maia
Lucas Oliveira Maia
LTLuís Fernando Tófoli
Luís Fernando Tófoli

1 February 2022 in Journal of Psychopharmacology
Verified
Journal Article
Closed access
IWIsabel Wießner
Isabel Wießner
MFMarcelo Falchi
Marcelo Falchi
LMLucas Oliveira Maia
Lucas Oliveira Maia
DDDimitri Daldegan-Bueno
Dimitri Daldegan-Bueno
FPFernanda Palhano-Fontes
Fernanda Palhano-Fontes
LTLuís Fernando Tófoli
Luís Fernando Tófoli
Background: Controversy surrounds psychedelics and their potential to boost creativity. To date, psychedelic studies lack a uniform conceptualization of creativity and methodologically rigorous designs. Aims: This study aimed at addressing previous issues by examining the effects of lysergic acid diethylamide (LSD) on creativity using multimodal tasks and multidimensional approaches. Methods: In a randomized, double-blind, placebo-controlled, crossover study, 24 healthy volunteers received 50 μg of LSD or inactive placebo. Near drug peak, a creativity task battery was applied, including pattern meaning task (PMT), alternate uses task (AUT), picture concept task (PCT), creative metaphors task (MET) and figural creativity task (FIG). Creativity was assessed by scoring creativity criteria (novelty, utility, surprise), calculating divergent thinking (fluency, originality, flexibility, elaboration) and convergent thinking, computing semantic distances (semantic spread, semantic steps) and searching for data-driven special features. Results: LSD, compared to placebo, changed several creativity measurements pointing to three overall LSD-induced phenomena: (1) ‘pattern break’, reflected by increased novelty, surprise, originality and semantic distances; (2) decreased ‘organization’, reflected by decreased utility, convergent thinking and, marginally, elaboration; and (3) ‘meaning’, reflected by increased symbolic thinking and ambiguity in the data-driven results. Conclusion: LSD changed creativity across modalities and measurement approaches. Three phenomena of pattern break, disorganization and meaning seemed to fundamentally influence creative cognition and behaviour pointing to a shift of cognitive resources ‘away from normal’ and ‘towards the new’. LSD-induced symbolic thinking might provide a tool to support treatment efficiency in psychedelic-assisted therapy.

7 December 2020 in Journal of Psychoactive Drugs
Verified
Journal Article
Closed access
LMLucas Oliveira Maia
Lucas Oliveira Maia
DDDimitri Daldegan-Bueno
Dimitri Daldegan-Bueno
LTLuís Fernando Tófoli
Luís Fernando Tófoli
Diseases that threaten life raise existential questions that can be a source of psychological distress. Studies with psychedelics demonstrate therapeutic effects for anxiety and depression associated with life-threatening illnesses. Ayahuasca has been proposed as a possible therapeutic agent in the treatment of psychiatric disorders. Preliminary studies suggest that ayahuasca could promote therapeutic effects for people with physical illnesses. The aim of this study was to explore how the ritual use of ayahuasca during the treatment of severe physical illnesses (SPI) may influence the way people understand and relate to their illness, using qualitative methods to assess the participants’ perspectives. Participants who consumed ayahuasca ritualistically during the period of treatment for SPI were purposely chosen. Data were obtained through semi-structured interviews. A thematic analysis was performed with 14 individuals. The ritual experience with ayahuasca acted on the participants’ illness understanding through multiple psychological mechanisms, including introspection, self-analysis, emotional processing and catharsis, recall of autobiographical memories subjectively related to illness origin, illness resignification, and perspective changes. This study suggests that the experience with ayahuasca may facilitate illness acceptance through an influence on the meanings of the illness, life, and death. These changes may favor a more balanced relationship with illness and treatment.